Powering Pharma
& Clinical Genomics

The World’s Most Comprehensive Source
of Genomic Evidence

NEW REPORT: Key Findings from the Genomic Landscape for ALS
Discover profound insights from Genomenon’s comprehensive Genomic Landscape for ALS, and their impact on Pharma

Solutions for…

PHARMA
& BIOPHARMA

Optimize drug discovery and clinical trial target selection with an AI-driven genomic landscape for any disease

 

CLINICAL
DIAGNOSTIC LABS

Accelerate NGS variant interpretation with rapid search and insight into the full text of the genomic literature

 

I can say with certainty that without the findings obtained from Genomenon, I would not have been able to provide a diagnosis for this patient.


Lipika Ray, PhD, Rare Genomics Institute
Lipika Ray, PhD, Rare Genomics Institute

Genomenon’s methodology improved the efficiency and completeness of our literature review process.


Vice President, Translational Research & Development, Rare Pharmaceutical Company
Vice President, Translational Research & Development, Rare Pharmaceutical Company

We are world-renowned for the speed of our WGS interpretations, and using Mastermind has been a crucial step in accelerating our progress.


Shareef Nahas, Senior Director, Clinical Operations, Rady Children's Institute for Genomic Medicine
Shareef Nahas, Senior Director, Clinical Operations, Rady Children’s Institute for Genomic Medicine

I don’t consider a patient’s report complete unless every variant has been researched through Mastermind


Dr. Nikoletta Sidiropoulos, Medical Director of Genomic Medicine, University of Vermont Health Network
Dr. Nikoletta Sidiropoulos, Medical Director of Genomic Medicine, University of Vermont Health Network

We are able to cast a wider net and pick up the most clinically relevant articles with the full text search capabilities of Mastermind.


Sam Globus, PhD, Director of Scientific Operations, Celmatix
Sam Globus, PhD, Director of Scientific Operations, Celmatix

We looked for the best tools to accelerate literature curation and found there is no comparable solution in the market like Mastermind


James Hirmas, CEO, GenomeNext
James Hirmas, CEO, GenomeNext

Mastermind is the most exhaustive genomic knowledge base in existence, built by indexing nearly seven million full-text genomic articles and 500,000 supplemental data sets.


Bio-IT World
Bio-IT World

(Searching Mastermind by phenotype) will be invaluable in our ongoing work to diagnose and treat babies with rare diseases.


Shareef Nahas, Senior Director, Clinical Operations, Rady Children's Institute for Genomic Medicine
Shareef Nahas, Senior Director, Clinical Operations, Rady Children’s Institute for Genomic Medicine

GENOMENON NAMED GLOBAL GENOMICS COMPANY OF THE YEAR